India's Panacea, Osmotica Of U.S. Join On 18 Drugs For Global Market
This article was originally published in PharmAsia News
Executive Summary
Panacea Biotec of India and Osmotica Pharmaceutical of the U.S. have agreed to joint development of 18 drugs for the global market, each sharing the cost and profits.